This track will explore the latest breakthroughs in cancer genomics, focusing on the identification and characterization of somatic mutations. Discussions will include the implications of genomic profiling for precision oncology and personalized medicine.

This session will delve into the roles of oncogenes and tumor suppressor genes in cancer development and progression. Researchers will present findings on how these genetic factors contribute to tumorigenesis and therapeutic resistance.

This track will highlight the discovery of novel cancer biomarkers and their applications in early detection and treatment monitoring. Emphasis will be placed on the integration of biomarker research into clinical practice.

This session will focus on the role of epigenetic modifications in cancer biology, including DNA methylation and histone modification patterns. Researchers will discuss how these alterations influence gene expression and tumor behavior.

This track will examine the development and implementation of targeted therapies in cancer treatment. Presentations will cover the mechanisms of action, efficacy, and challenges associated with these innovative therapeutic approaches.

This session will address the advancements in molecular diagnostics for cancer, including mutation screening and genomic profiling techniques. The focus will be on how these diagnostics enhance patient stratification and treatment outcomes.